Joe E. Kiani CEO & Chairman of the Board Medical technology is a broad field where innovation plays a crucial role in sustaining health areas like information technology, the development of medical devices and equipment. With the advancements in medical technology, physicians are able to better diagnose and treat patients. “The latest healthcare development is integrating patient monitors, innovative parameters, wireless devices, workflows, and integrated IT solutions to create a fluent system of clinical intelligence,” says Joe E. Kiani, CEO, Masimo. Headquartered in Irvine, CA, Masimo (NASDAQ: MASI) develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors that leads to improved accuracy and reduction in the overall number of false readings, and ultimately reduces cost of care. “Our non invasive technology is revolutionizing patient monitoring, including Masimo SET pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous monitoring technology,” he adds.
Founded in 1989, Masimo is committed to improve patient outcomes and reduce cost of care. “We achieve this by partnering with patient monitoring companies and caregivers and creating innovative, cost-effective acquisition programs for Masimo SET products for the benefit of the patients,” states Kiani.
The company’s measure-through motion and low perfusion pulse oximetry, Masimo SET (Signal Extraction Technology) outperforms other pulse oximetry technologies, under the most challenging clinical conditions. “In addition, SET pulse oximetry provides perfusion index (PI) and pleth variability index (PVI) which increases the ability to detect life-threatening events and reduce false alarms during challenging conditions.”
Masimo’s SafetyNet, is a remote monitoring and wireless clinician notification system designed to help hospitals avoid preventable deaths and injuries associated with failure to rescue events. It displays real-time information from any connected Masimo device at a central station and allows for alarms and alerts from the bedside devices to be sent directly to clinicians via pager or third party gateway to IP phones. “We have introduced Halo Index in the Patient SafetyNet system, combining multiple physiologic parameters into one number to help clinicians assess overall patient status,” adds Kiani.
Our non invasive technology is revolutionizing patient monitoring, including Masimo SET pulse oximetry, Masimo Rainbow Pulse CO-Oximetry and new Masimo noninvasive and continuous monitoring technology
Some of the company’s significant product releases include—Root, an intuitive patient monitoring and connectivity platform designed to transform patient care from the operating room to the Intensive Care Unit (ICU) to the general floor. Masimo has also introduced CE Mark O3 regional oximetry for the Root patient monitoring and connectivity platform. The company has added, Radius-7 for the Root patient monitoring and connectivity platform, a wearable, wireless monitor with Masimo’s rainbow SET technology, enabling early identification of clinical deterioration while offering patients continuous monitoring with freedom of movement.
The company has created a non-profit Patient Safety Movement Foundation with a mission to eliminate the more than 200,000 preventable patient deaths that occur in U.S. hospitals each year. For the years to come, Masimo plans to create patient monitoring technologies that are more effective and reliable and improves patient outcomes. “We provide patient safety by giving health care providers the information they need to optimize clinical decision-making,” says Kiani.
